Translational Research Platform based on human tissues and primary cells

Humana Biosciences is a Preclinical Contract Research Organization based in France. We are focused on translational research assays. The company offers preclinical research services to Pharma, biotech & nutraceutical companies, as well as Academic Laboratories based in Europe and developing novel drugs or nutritional solutions in the following therapeutic areas: Dermatology, Gastro-Intestinal, Respiratory, Urology and Gynecology.

What We Offer to Horizon Europe Consortia

1. New Approach Methodologies (NAMs) / Alternative to Animal Testing

• Validated technologies and assays to generate human-relevant, functional cellular readouts, like:

• Human tissues obtained from European Hospitals (fresh, frozen and paraffin-embedded) from healthy controls as well as selected patients

• Human primary cells in 3D cultures

• Human isolated organs for smooth muscle contractility studies and neurotransmitters release

 2. Advanced Tools for testing chemicals and drug candidates

• Large experience in testing small molecules, peptides, plant extracts and Advanced Therapy Medicinal Products.

• Real-time monitoring of tumor cell lines or human primary epithelial cells and immune cells isolated from healthy individuals or patients to evaluate cell viability, proliferation and growth inhibition.

• Real-Time Cell Metabolic Analysis, providing a clear window into the critical functions driving cell signaling, proliferation, activation, toxicity and biosynthesis.

 3. Regulatory Science & Translational Development

• Expertise in designing robust analytical assays for drug discovery and safety assessment.

• Strong alignment with calls requiring quantitative, reproducible, patient-relevant data.

What we are looking for (ideal consortium fit):

We are interested in joining consortia that aim to develop or validate NAM platforms (e.g., human primary cells in 3D cultures, human tissue-relevant assays, pharmacological characterization of receptors in functional assays on human isolated tissues, as well as imaging readouts, requested by our partners to characterize and validate new drug candidates.